Prevalence of Periprocedural Complications and Associated Factors of Percutaneous Coronary Intervention in Patients with Ischemic Heart Disease at Coronary Care Units of Tikur Anbessa Specialized Hospital and Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia: A Retrospective Cohort Study

References

• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. Journal of the American College of Cardiology ; 2022. Available from: doi:10.1016/j.jacc.2019.10.009. Accessed August 30, 2023.
   Google Scholar
• Misganaw A, Mariam DH, Ali A, Araya T. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Health Popul Nutr. 2014;32(1):1.
   PubMed Web of Science ®Google Scholar
• Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):1–9. doi:10.1186/s12872-020-01828-z
   PubMed Web of Science ®Google Scholar
• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
   PubMed Web of Science ®Google Scholar
• Prabhakaran D, Jeemon P, Sharma M, et al. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1339–e1351. doi:10.1016/S2214-109X(18)30407-8
   PubMed Web of Science ®Google Scholar
• Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1483–1492. doi:10.1161/CIRCULATIONAHA.113.004042
   PubMed Web of Science ®Google Scholar
• Khan MA, Hashim MJ, Mustafa H, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12(7). doi:10.7759/cureus.9349
   Web of Science ®Google Scholar
• Mensah G. Ischaemic heart disease in Africa. Heart. 2008;94(7):836–843. doi:10.1136/hrt.2007.136523
   PubMed Web of Science ®Google Scholar
• Maru M. The changing pattern of cardiovascular diseases in Ethiopia. East Afr Med J. 1993;70(12):772–776.
   PubMed Web of Science ®Google Scholar
• Shashu BA, Ayele MA. The pattern of coronary artery diseases as diagnosed by coronary angiography and the outcome of Percutaneous Coronary Intervention (PCI) in Ethiopia. Ethiop J Health Dev. 2014;28(1):1.
   Google Scholar
• Khan SQ, Ludman PF. Percutaneous coronary intervention. Medicine. 2022;50(7):437–444. doi:10.1016/j.mpmed.2022.04.008
   Google Scholar
• Canfield J, Totary-Jain H. 40 years of percutaneous coronary intervention: history and future directions. J Pers Med. 2018;8(4):33. doi:10.3390/jpm8040033
   PubMed Web of Science ®Google Scholar
• Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701–706. doi:10.1056/NEJM198703193161201
   PubMed Web of Science ®Google Scholar
• The management of coronary artery disease in Ethiopia: emphasis on revascularization. Ethiopian Journal of Health Sciences; 2022 Available from: https://www.ajol.info/index.php/ejhs/article/view/207206. Accessed August 30, 2023.
   Google Scholar
• Doll JA, Hira RS, Kearney KE, et al. Management of percutaneous coronary intervention complications. Circ Cardiovasc Interv. 2020;13(6):e008962. doi:10.1161/CIRCINTERVENTIONS.120.008962
   PubMed Web of Science ®Google Scholar
• Bauer T, Boeder N, Nef HM, et al. Fate of patients with coronary perforation complicating percutaneous coronary intervention (from the euro heart survey percutaneous coronary intervention registry). Am J Cardiol. 2015;116(9):1363–1367. doi:10.1016/j.amjcard.2015.07.056
   PubMed Web of Science ®Google Scholar
• Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty – PubMed; 2022. Available from: https://pubmed.ncbi.nlm.nih.gov/29808821/. Accessed August 30, 2023.
   Google Scholar
• Fanaroff AC, Zakroysky P, Dai D, et al. Outcomes of PCI in relation to procedural characteristics and operator volumes in the United States. J Am Coll Cardiol. 2017;69(24):2913–2924. doi:10.1016/j.jacc.2017.04.032
   PubMed Web of Science ®Google Scholar
• George S, Butler R, Nolan J, Mamas MA. Percutaneous coronary intervention and bleeding complications. Eur Med J. 2016;4(1):100–109.
   Google Scholar
• Ischemic stroke after percutaneous coronary intervention: rare, but devastating*. JACC: Cardiovascular Interventions; 2022. Available from: doi:10.1016/j.jcin.2019.05.013. Accessed August 30, 2023.
   Google Scholar
• Shoukat S, Gowani SA, Jafferani A, Dhakam SH. Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract. 2010;2010:e649164. doi:10.4061/2010/649164
   PubMedGoogle Scholar
• Stathopoulos I, Jimenez M, Panagopoulos G, Kwak E. The decline in PCI complication rate: 2003–2006 versus 1999–2002. Hellenic J Cardiol. 2009;50(5):379–387.
   PubMed Web of Science ®Google Scholar
• Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;53(12):C12–C16. doi:10.1016/0002-9149(84)90738-0
   Web of Science ®Google Scholar
• Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981. N Engl J Med. 1988;318(5):265–270. doi:10.1056/NEJM198802043180501
   PubMed Web of Science ®Google Scholar
• Agrawal SK, Ho DSW, Liu MW, et al. Predictors of thrombotic complications after placement of the flexible coil stent. Am J Cardiol. 1994;73(16):1216–1219. doi:10.1016/0002-9149(94)90186-4
   PubMed Web of Science ®Google Scholar
• Ellis SG, Roubin GS, King SB, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8207 procedures. J Am Coll Cardiol. 1988;11(2):211–216. doi:10.1016/0735-1097(88)90082-4
   PubMed Web of Science ®Google Scholar
• Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol. 1995;26(4):931–938. doi:10.1016/0735-1097(95)00294-4
   PubMed Web of Science ®Google Scholar
• Khalfallah M, Allaithy A, Maria DA. Incidence, predictors and outcomes of contrast induced nephropathy in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Glob Heart. 2021;16(1). doi:10.5334/gh.1071
   PubMed Web of Science ®Google Scholar
• Valappil SP, Kunjukrishnapillai S, Iype M, et al. Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty—a study from a tertiary care center in South India. Indian Heart J. 2018;70(3):399–404. doi:10.1016/j.ihj.2017.08.018
   PubMedGoogle Scholar
• Wang J, Zhang C, Liu Z, Bai Y. Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis. J Int Med Res. 2021;49(4):03000605211005972. doi:10.1177/03000605211005972
   PubMed Web of Science ®Google Scholar
• Numasawa Y, Kohsaka S, Ueda I, et al. Incidence and predictors of bleeding complications after percutaneous coronary intervention. J Cardiol. 2017;69(1):272–279. doi:10.1016/j.jjcc.2016.05.003
   PubMed Web of Science ®Google Scholar
• Qian G, Fu Z, Guo J, Cao F, Chen Y. Prevention of contrast-induced nephropathy by central venous pressure–guided fluid administration in chronic kidney disease and congestive heart failure patients. JACC Cardiovasc Interv. 2016;9(1):89–96. doi:10.1016/j.jcin.2015.09.026
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Huang F. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):1–12. doi:10.1186/s12872-018-0820-6
   PubMedGoogle Scholar
• Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(20):1815–1823. doi:10.1016/S0195-668X(03)00485-8
   PubMed Web of Science ®Google Scholar
• Kent KC, Moscucci M, Mansour KA, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–913. doi:10.1016/0741-5214(94)90227-5
   PubMed Web of Science ®Google Scholar